Cargando…

HPV and cervical cancer: screening or vaccination?

Following the demonstration of the superior validity of human papillomavirus (HPV) tests in screening for cervical cancer and the arrival of highly efficacious HPV 16 and 18 vaccines, cervical cancer prevention enters a time of sustainable introduction in developing countries. Multidisciplinary effo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosch, F X, Castellsagué, X, de Sanjosé, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359713/
https://www.ncbi.nlm.nih.gov/pubmed/18182975
http://dx.doi.org/10.1038/sj.bjc.6604146
_version_ 1782152898641133568
author Bosch, F X
Castellsagué, X
de Sanjosé, S
author_facet Bosch, F X
Castellsagué, X
de Sanjosé, S
author_sort Bosch, F X
collection PubMed
description Following the demonstration of the superior validity of human papillomavirus (HPV) tests in screening for cervical cancer and the arrival of highly efficacious HPV 16 and 18 vaccines, cervical cancer prevention enters a time of sustainable introduction in developing countries. Multidisciplinary efforts and novel protocols are being developed, and challenging situations are being faced to make cervical cancer, still the number two cancer in women worldwide, an eradicable condition.
format Text
id pubmed-2359713
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23597132009-09-10 HPV and cervical cancer: screening or vaccination? Bosch, F X Castellsagué, X de Sanjosé, S Br J Cancer Minireview Following the demonstration of the superior validity of human papillomavirus (HPV) tests in screening for cervical cancer and the arrival of highly efficacious HPV 16 and 18 vaccines, cervical cancer prevention enters a time of sustainable introduction in developing countries. Multidisciplinary efforts and novel protocols are being developed, and challenging situations are being faced to make cervical cancer, still the number two cancer in women worldwide, an eradicable condition. Nature Publishing Group 2008-01-15 2008-01-08 /pmc/articles/PMC2359713/ /pubmed/18182975 http://dx.doi.org/10.1038/sj.bjc.6604146 Text en Copyright © 2008 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Minireview
Bosch, F X
Castellsagué, X
de Sanjosé, S
HPV and cervical cancer: screening or vaccination?
title HPV and cervical cancer: screening or vaccination?
title_full HPV and cervical cancer: screening or vaccination?
title_fullStr HPV and cervical cancer: screening or vaccination?
title_full_unstemmed HPV and cervical cancer: screening or vaccination?
title_short HPV and cervical cancer: screening or vaccination?
title_sort hpv and cervical cancer: screening or vaccination?
topic Minireview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359713/
https://www.ncbi.nlm.nih.gov/pubmed/18182975
http://dx.doi.org/10.1038/sj.bjc.6604146
work_keys_str_mv AT boschfx hpvandcervicalcancerscreeningorvaccination
AT castellsaguex hpvandcervicalcancerscreeningorvaccination
AT desanjoses hpvandcervicalcancerscreeningorvaccination